Advertisement

CRST Europe Chief Medical Editor Awarded 2009 Choyce Medal

  • Share
  • E-mail
  • Print


Cataract & Refractive Surgery Today Europe's Co-Chief Medical Editor Sheraz M. Daya, MD, FACP, FACS, FRCS(Ed), received the 2009 Choyce Medal and delivered the Choyce Medal Lecture 2009 at the United Kingdom and Ireland Society of Cataract and Refractive Surgeons (UKISCRS) in October 2009. This award, presented every 2 years to an ophthalmologist who has made a significant contribution to the field in Europe, is named after Peter Choyce, MD, a pioneer of artificial lens implantation following cataract extraction, and founding member of the International Intraocular Implant Club (IIIC). Diane Choyce, the widow of the late Mr. Choyce, presented the medal to Dr. Daya.

Dr. Daya is Medical Director and Consultant in the Corneoplastic Unit and Eye Bank at the Queen Victoria Hospital, East Grinstead, United Kingdom, as well as Founder and Medical Director of Centre for Sight in London and East Grinstead. He has been involved in innovative work in cornea, anterior segment and keratorefractive surgery. Dr. Daya's lecture outlines his many wide-ranging contributions at the East Grinstead's Corneoplastic unit over the past 16 years, including stem cell transplantation, particularly ex vivo stem cell transplantation and lamellar grafting and its applications beyond conventional transplantation.

"It is very flattering to be awarded this honor, especially following so many well-known recipients, including Richard Lindstrom, MD, under whom I was a fellow in 1991," Dr. Daya said in an interview with CRST Europe. "Preparing this lecture made me realize the wide spectrum of work carried out at the Corneoplastic Unit over the last 16 years. This award is a tribute to all the fellows and staff who have been so supportive and open to innovation and change.

"The unit has grown considerably, especially over the last 7 years, with the inclusion of two more consultant colleagues: Raman Malhotra, FRCOphth, who provides oculoplastic expertise and, more recently, Damian Lake, MB ChB(Glas), FRCOphth, in the area of cornea," Dr. Daya commented. "Based on feedback I have received, many colleagues were unaware of the depth and breadth of work conducted at our unit. I am pleased I had the opportunity to convey this to my colleagues."

Click here for more industry news and clinical trial updates.

You must be logged in to leave a comment.

TOP 5 ARTICLES FROM 2009